Alexandria Real Estate Equities, Inc. 

(Public, NYSE:ARE)   Watch this stock   
Find more results for ARE
Nov 5, 2009
Q3 2009 Conference Call
Nov 5, 2009
Q3 2009 Release
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2008
Net profit margin 22.05% 24.11%
Operating margin 22.05% 24.11%
EBITD margin - 64.71%
Return on average assets 1.90% 2.27%
Return on average equity 3.83% 6.23%
Employees 152 -

Address

385 East Colorado Boulevard Suite 299
Pasadena, CA 91101
United States - Map
+1-626-5780777 (Phone)
+1-626-5780770 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com
Discussion Group - Google Finance

Alexandria Real Estate Equities, Inc. discussed on blogs

Ranking 700+ Mid-Cap Stocks by Profit Margin - NASD100.com - Daily ... - Investor's Resources - NASD100.com - Daily Stock Rankings - Nov 20, 2009

Description

Alexandria Real Estate Equities, Inc. is a real estate investment trust (REIT) focused on the cluster formation. The Company is a provider of real estate, technical infrastructure services and capital to the life science industry. The clients of the Company include institutional (universities and independent not-for-profit institutions), pharmaceutical, biopharmaceutical, medical device, product, service, and translational entities, as well as government agencies. During the year ended December 31, 2008, the Company executed 141 leases for approximately 2.2 million square feet. The Company completed the redevelopment of multiple spaces at 14 properties aggregating approximately 335,000 rentable square feet. In 2008, the Company leased approximately 630,000 rentable square feet of redevelopment and development space.

Officers and directors

Joel S. Marcus
Chairman of the Board, President, Chief Executive Officer
Age: 61
Bio & Compensation - Reuters
Dean A. Shigenaga
Chief Financial Officer, Senior Vice President, Treasurer
Age: 42
Bio & Compensation - Reuters
Richard B. Jennings
Lead Director
Age: 65
Bio & Compensation - Reuters
James H. Richardson
Director
Age: 49
Bio & Compensation - Reuters
Alan G. Walton Ph.D.
Director
Age: 73
Bio & Compensation - Reuters
Richard H. Klein
Director
Age: 53
Bio & Compensation - Reuters
Martin A. Simonetti
Director
Age: 51
Bio & Compensation - Reuters